Discover 1,743 paid clinical trials in Ann Arbor, Michigan. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 1,743
The Use of Impella RP Support System in Patients With Right Heart Failure
for
Right Heart Failure
Location: Detroit MI, Philadelphia PA
Sponsor: Abiomed Inc.
Sex: All
Age: 18+
Code: NCT01777607
Recruiting
MammaPrint, BluePrint, and Full-genome Data Linked With Clinical Data to Evaluate New Gene EXpression Profiles
for
Breast Cancer
Location: Royal Oak MI, Troy MI, Grosse Pointe Woods MI,
Sponsor: Agendia
Sex: All
Age: 18+
Code: NCT03053193
Recruiting
CHERL, Connecting Primary Care Patients With Community Resources to Facilitate Behavior Change
for
Tobacco Use Disorder, Alcohol Abuse, Lack of Physical Activity,
Location: Flint MI, Grand Rapids MI, Marquette MI
Sponsor: Great Lakes Research Into Practice Network
Sex: All
Age: 18+
Code: NCT00269009
Phase1, Recruiting
A Study to Investigate Subcutaneous Isatuximab in Combination With Weekly Carfilzomib and Dexamethasone in Adult Participants With Relapsed and/or Refractory Multiple Myeloma
for
Plasma Cell Myeloma Refractory
Location: Dearborn MI, Royal Oak MI, Canton OH, Cincinnati OH,
Sponsor: Sanofi
Sex: All
Age: 18+
Code: NCT06356571
Phase2, Recruiting
A Study to Find Out if Enfortumab Vedotin Given With Pembrolizumab Helps People With Muscle-invasive Bladder Cancer Keep Their Bladder
for
Muscle-invasive Bladder Cancer
Location: Royal Oak MI, Chicago IL, Lisle IL, Willow Grove PA,
Sponsor: Astellas Pharma Global Development, Inc.
Sex: All
Age: 18+
Code: NCT07475806
Phase2, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
ROSETTA Breast-01: The Effects and Safety of Pumitamig in Patients With Triple-Negative Breast Cancer
for
Breast Neoplasms
Location: Royal Oak MI, Detroit MI, Milwaukee WI, Urbana IL,
Location: Royal Oak MI, Detroit MI, Cleveland OH, Zanesville OH,
Sponsor: Hospital Quality Foundation
Sex: All
Age: 18+
Code: NCT02745054
Recruiting
Study of Sacituzumab Govitecan-hziy and Pembrolizumab Versus Treatment of Physician's Choice in Patients With Triple Negative Breast Cancer Who Have Residual Invasive Disease After Surgery and Neoadjuvant Therapy (ASCENT-05/AFT-65 OptimICE-RD/GBG 119/NSABP B-63)
for
Triple Negative Breast Cancer
Location: Royal Oak MI, Grand Rapids MI, Columbus OH, Chicago IL,
Sponsor: Gilead Sciences
Sex: All
Age: 18+
Code: NCT05633654
Phase3, Recruiting
Valve Hemodynamic Optimization Based on Doppler-Echocardiography vs Catheterization Measurements Following ViV TAVR